| S.No |
Particulars |
Click here link |
| A |
Details of its business:
- Company Overview
- Business Operations
Business Segments |
https://www.divislabs.com/api-manufacturing-company/
https://www.divislabs.com/pharmaceutical-company/
https://www.divislabs.com/api-manufacturer-world/ |
| B |
Terms and conditions of appointment of independent directors |
https://www.divislabs.com/wp-content/uploads/2022/04/Terms-Conditions-of-Appointment-of-Independent-Directors.pdf |
| C |
Composition of various committees of board of directors |
https://www.divislabs.com/investor-relations/corporate-governance/composition-of-committees/ |
| D |
Code of conduct of board of directors and senior management personnel |
https://www.divislabs.com/wp-content/uploads/2022/02/Code-of-Ethics-and-Business-Conduct-of-Divis-Laboratories-Limited.pdf
|
| E |
Details of establishment of vigil mechanism/ Whistle Blower policy |
https://www.divislabs.com/wp-content/uploads/2020/06/WhistleBlowerPolicy.pdf
|
| F |
Criteria of making payments to non-executive directors – disclosed in annual reports |
https://www.divislabs.com/investor-relations/reports-and-filings/annual-reporting/
|
| G |
Policy on dealing with related party transactions |
https://www.divislabs.com/wp-content/uploads/2022/04/RPT-policy.pdf
|
| H |
Policy for determining ‘material’ subsidiaries |
https://www.divislabs.com/wp-content/uploads/2020/06/Policy-on-Material-Subsidiary_-revised-2019-Clean.pdf
|
| I |
Details of familiarization programmes imparted to independent directors |
https://www.divislabs.com/wp-content/uploads/2023/04/Familiarisation-programs-2023.pdf
|
| J |
Email address for grievance redressal and other relevant details |
https://www.divislabs.com/investor-relations/shareholders-contact/
|
| K |
Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievances |
https://www.divislabs.com/investor-relations/shareholders-contact/
|
| L |
Financial information including:
(i) Notice of meeting of the board of directors where financial results shall be discussed;
(ii) Financial results, on conclusion of the meeting of the board of directors where the financial results were approved;
(iii) Complete copy of the annual report including balance sheet, profit and loss account, directors report, corporate governance report etc; |
https://www.divislabs.com/investor-relations/statutory-communication/
https://www.divislabs.com/investor-relations/reports-and-filings/quarterly-reporting/
https://www.divislabs.com/investor-relations/reports-and-filings/annual-reporting/
|
| M |
Shareholding pattern |
https://www.divislabs.com/investor-relations/reports-and-filings/shareholding-pattern/
|
| N |
Details of agreements entered into with the media companies and/or their associates, etc |
Not Applicable |
| O |
Schedule of analysts or institutional investors meet and presentations made by the listed entity to analysts or institutional investors |
https://www.divislabs.com/investor-relations/statutory-communication/#investor-meetings-&-earnings-call
|
| OA |
Audio or video recordings and transcripts of post earnings/quarterly calls, the transcripts of such calls |
https://www.divislabs.com/investor-relations/statutory-communication/#investor-meetings-&-earnings-call
|
| P |
New name and the old name of the listed entity for a continuous period of one year, from the date of the last name change |
Not Applicable |
| Q |
Newspaper advertisements – items in sub-regulation (1) of regulation 47 |
https://www.divislabs.com/investor-relations/statutory-communication/#2022-23
|
| R |
Credit rating obtained by the Company |
https://www.divislabs.com/investor-relations/statutory-communication/#credit-rating
|
| S |
Separate audited financial statements of each subsidiary of the Company |
https://www.divislabs.com/investor-relations/reports-and-filings/annual-reporting/#subsidiary-financials/
|
| T |
Secretarial compliance report as per sub-regulation (2) of regulation 24A of these regulations |
https://www.divislabs.com/investor-relations/reports-and-filings/AnnualSecretarialcompliancereport
|
| U |
Disclosure of the policy for determination of materiality of events or information required under clause (ii), sub-regulation (4) of regulation 30 of these regulations |
https://www.divislabs.com/wp-content/uploads/2020/06/Policy-on-Determination-of-Materiality-revised-on-10.08.2019.pdf
|
| V |
Disclosure of contact details of key managerial personnel who are authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s) as required under subregulation (5) of regulation 30 of these regulations |
https://www.divislabs.com/wp-content/uploads/2020/06/Policy-on-Determination-of-Materiality-revised-on-10.08.2019.pdf
|
| W |
Disclosures under sub-regulation (8) of regulation 30 of these regulations |
https://www.divislabs.com/investor-relations/statutory-communication/
|
| X |
Statements of deviation(s) or variation(s) as specified in regulation 32 of these regulations |
Not Applicable |
| Y |
Dividend distribution policy by listed entities based on market capitalization as specified in sub-regulation (1) of regulation 43A |
https://www.divislabs.com/wp-content/uploads/2018/07/Dividend-Distribution-Policy.pdf
|
| Z |
Annual return as provided under section 92 of the Companies Act, 2013 and the rules made thereunder |
https://www.divislabs.com/investor-relations/reports-and-filings/annual-return/
|
